Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive Ethanol Lock Therapy for CRI in Pediatric Oncology
NCT02095951Phase 4Completed
- Sponsor
- Children's Hospital of Michigan
- Start
- Jun 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ethanol in Catheter-related infection (CRI) (2 arms), sponsored by Children's Hospital of Michigan. Primary endpoints: Length of Stay, Attributable Length of Stay and 1 more. Started Jun 2014; status: completed.
02
Drugs
ethanol
03
Conditions
Catheter-related infection (CRI)
Beyond the preview
Go deeper on NCT02095951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02095951.